| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.39▼ | 2.40▼ | 2.40▼ | 2.41▼ | 2.05▲ |
| MA10 | 2.39▼ | 2.41▼ | 2.41▼ | 2.27▲ | 2.03▲ |
| MA20 | 2.40▼ | 2.41▼ | 2.42▼ | 2.02▲ | 2.03▲ |
| MA50 | 2.41▼ | 2.41▼ | 2.34▲ | 1.99▲ | 1.66▲ |
| MA100 | 2.41▼ | 2.33▲ | 2.12▲ | 2.01▲ | 1.47▲ |
| MA200 | 2.42▼ | 2.09▲ | 1.99▲ | 1.76▲ | 1.39▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.005▼ | -0.012▼ | 0.058▲ | 0.011▲ |
| RSI | 34.870▼ | 41.170▼ | 47.449▼ | 65.931▲ | 60.475▲ |
| STOCH | 48.333 | 33.333 | 35.287 | 91.605▲ | 36.889 |
| WILL %R | -100.000▼ | -100.000▼ | -66.667 | -9.574▲ | -36.496 |
| CCI | -145.833▼ | -144.322▼ | -168.724▼ | 85.312 | 130.971▲ |
|
Thursday, May 01, 2025 01:34 PM
Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to ...
|
|
Thursday, May 01, 2025 05:00 AM
Akebia to Host Conference Call on May 8, 2025, at 8:00 a.m. EDTCAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its ...
|
|
Monday, April 28, 2025 09:00 AM
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 2.41 | 2.45 | 2.38 | 2.39 | 2,416,795 |
| 30/04/25 | 2.36 | 2.45 | 2.34 | 2.41 | 3,578,594 |
| 29/04/25 | 2.425 | 2.48 | 2.37 | 2.425 | 2,506,394 |
| 28/04/25 | 2.48 | 2.48 | 2.34 | 2.43 | 2,561,663 |
| 25/04/25 | 2.26 | 2.40 | 2.26 | 2.38 | 2,257,850 |
| 24/04/25 | 2.16 | 2.28 | 2.15 | 2.28 | 2,299,111 |
| 23/04/25 | 2.18 | 2.27 | 2.15 | 2.16 | 2,745,758 |
| 22/04/25 | 2.11 | 2.15 | 2.06 | 2.14 | 1,874,603 |
| 21/04/25 | 2.02 | 2.16 | 2.01 | 2.07 | 2,669,501 |
| 17/04/25 | 1.90 | 2.13 | 1.90 | 2.06 | 4,591,210 |
|
|
||||
|
|
||||
|
|